Effect of methylenetetrahydrofolate reductase C677T polymorphism on serum folate but not vitamin B12 levels in patients with H-type hypertension

被引:0
作者
Lijuan Ma
Jing Li
Yuan Yuan
Wenwen Chen
Jun Zhao
机构
[1] Xinjiang Medical University Affiliated First Hospital,Department of Pharmacy
[2] The Precision Medicine Center of Xinjiang Medical University,undefined
来源
Molecular Biology Reports | 2022年 / 49卷
关键词
H-type hypertension; Homocysteine; Methylenetetrahydrofolate reductase; Folate; Vitamin B12;
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
页码:9535 / 9541
页数:6
相关论文
共 84 条
[1]  
Finkelstein JD(2000)Homocysteine Int J Biochem Cell Biol 32 385-389
[2]  
Martin JJ(2021)Homocysteine, B vitamins, and cardiovascular disease: a Mendelian randomization study BMC Med 325 1202-1206
[3]  
Yuan S(2002)Homocysteine and cardiovascular disease: evidence on causality from a meta-analysis BMJ 24 24-56
[4]  
Mason AM(2019)2018 Chinese guidelines for the management of hypertension J Cardiovasc Med 24 123-127
[5]  
Carter P(2016)Expert consensus on diagnosis and treatment of H-type hypertension Chin J Hypertens 132 e6-e9
[6]  
Wald DS(2015)Homocysteine and MTHFR mutations Circulation 38 679-685
[7]  
Li JP(2018)MTHFR gene and serum folate interaction on serum homocysteine lowering: prospect for precision folic acid treatment Arterioscler Thromb Vasc Biol 39 125-130
[8]  
Lu XZ(2008)The 677 C/T MTHFR polymorphism is associated with essential hypertension, coronary artery disease, and higher homocysteine levels Arch Med Res 12 698590-90
[9]  
Huo Y(2021)Association between MTHFR polymorphisms and the risk of essential hypertension: an updated meta-analysis Front Genet 2022 2144443-328
[10]  
Moll S(2022)Methylenetetrahydrofolate reductase gene rs1801133 and rs1801131 polymorphisms and essential hypertension risk: a comprehensive analysis Cardiovasc Ther 302 401-e1136